BIO vs ILMN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
BIO
ILMN
Investment Advisor Scores
ILMN
Oct 21, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | BIO | ILMN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 41.3223 | 40.3226 | ILMN |
| PEG Ratio | 1.1905 | 3.0533 | BIO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -0.1% | 9.4% | ILMN |
| Earnings Growth | 18.7% | -9.4% | BIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 70.1/100 | 41.9/100 | BIO |
| Profit Margin | 8.6% | 18.3% | ILMN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | HOLD | BIO |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BIO
NeutralMixed signals - no dominant trend phase, RSI 46
ILMN
MarkupPrice above SMA50, rising 50-day trend (15.1% over 20 days), RSI 63
Fundamentals Snapshot
| Metric | BIO | ILMN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 37.0 | 46.2 |
| Trailing P/E | 44.9 | 50.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 7.89 | 5.36 |
| Dividend Yield | — | — |